B. Riley FBR analyst Randy Binner said the multi-state investigations into Health Insurance Innovations related to claims-paying practices, agent appointments, and call center sales practices "effectively came out of the HCC process approximately two years ago." He believes that the news regarding HCC Life settling its own multistate investigation for $5M is a favorable sign that Health Insurance Innovations' matter will be successfully resolved. He maintains a Buy rating and $45 price target on Health Insurance Innovations shares, which are up 5% to $29.75 in morning trading.